These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 1794437
1. Induction of immune resistance against L1210 lymphatic leukemia in mice after lethal irradiation and reconstruction with fetal liver cells. Skórski T, Ratajczak MZ, Kawalec M, Kawiak J. Folia Histochem Cytobiol; 1991; 29(3):121-4. PubMed ID: 1794437 [Abstract] [Full Text] [Related]
2. Induction of immune resistance against L1210 lymphatic leukemia in mice after chemoradiotherapy of the leukemia and reconstitution with bone marrow purged from the leukemia with mafosfamide. Skórski T, Kawalec M. Exp Hematol; 1988 Oct; 16(9):782-4. PubMed ID: 3049130 [Abstract] [Full Text] [Related]
3. Recovery of the ability to induce immune resistance against L1210 lymphatic leukemia in semisyngeneic CD2F1 mice after lethal irradiation and reconstitution with bone marrow purged of leukemia with mafosfamide (ASTA Z 7654). Skórski T, Kawalec M. Bone Marrow Transplant; 1987 Dec; 2(4):435-40. PubMed ID: 3332191 [Abstract] [Full Text] [Related]
4. Early induction of immune resistance against leukemia in lethally total body irradiated mice reconstituted with syngeneic bone marrow cells obtained from previously immunized donor mice. Skorski T, Kawalec M, Kawiak J. Bone Marrow Transplant; 1990 Jan; 5(1):23-7. PubMed ID: 2297588 [Abstract] [Full Text] [Related]
5. Early induction of immune resistance against leukemia in mice after lethal irradiation followed by syngeneic bone marrow transplantation and injection of syngeneic leukocytes. Skórski T, Kawalec M, Kawiak J. Transplantation; 1991 Apr; 51(4):843-7. PubMed ID: 2014540 [Abstract] [Full Text] [Related]
6. Successful chemoimmunotherapy of murine L1210 lymphatic leukemia with cyclophosphamide and mafosfamide-treated leukemia cells. Kawalec M, Skórski T, Kawiak J. Invest New Drugs; 1988 Sep; 6(3):169-72. PubMed ID: 3192382 [Abstract] [Full Text] [Related]
7. The kinetics of immunologic and hematologic recovery in mice after lethal total body irradiation and reconstitution with syngeneic bone marrow cells treated or untreated with mafosfamide (ASTA Z 7654). Skórski T, Kawalec M, Hoser G, Ratajczak M, Gnatowski B, Kawiak J. Bone Marrow Transplant; 1988 Nov; 3(6):543-51. PubMed ID: 2905613 [Abstract] [Full Text] [Related]
8. New application of a stabilized active cyclophosphamide derivative (mafosfamide, ASTA Z 7654)--immunogenic properties of lymphatic leukemia L 1210 cells treated in vitro with the drug. Skórski T, Kawalec M. Invest New Drugs; 1987 Nov; 5(2):167-9. PubMed ID: 3654151 [Abstract] [Full Text] [Related]
9. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity. Ujiie T. Jpn J Cancer Res; 1987 Jul; 78(7):737-47. PubMed ID: 3114200 [Abstract] [Full Text] [Related]
10. [Transplantation of mesenchymal derived stem cells followed by G-CSF injection can reconstitute hematopoiesis of lethally irradiated BALB/c mice]. Hu Y, Ma L, Ma GJ, Jiang XY, Zhao CH. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):20-4. PubMed ID: 12905834 [Abstract] [Full Text] [Related]
11. Leukemia inhibitory factor induces in vivo expansion of bone marrow progenitor cells that accelerate hematopoietic reconstitution but do not enhance radioprotection in lethally irradiated mice. Pruijt JF, Lindley IJ, Heemskerk DP, Willemze R, Fibbe WE. Stem Cells; 1997 Feb; 15(1):50-5. PubMed ID: 9007222 [Abstract] [Full Text] [Related]
12. Immunogenic and nondividing mafosfamide-treated L 1210 cells--comparison of lines resistant and nonresistant to cyclophosphamide. Kawalec M, Hoser G, Skórski T, Kawiak J. Folia Histochem Cytobiol; 1993 Feb; 31(2):63-6. PubMed ID: 8405569 [Abstract] [Full Text] [Related]
13. Biochemical effects and therapeutic potential of tunicamycin in murine L1210 leukemia. Morin MJ, Bernacki RJ. Cancer Res; 1983 Apr; 43(4):1669-74. PubMed ID: 6339042 [Abstract] [Full Text] [Related]
14. Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A. Kataoka T, Oh-hashi F, Tsukagoshi S, Sakurai Y. Cancer Res; 1977 Apr; 37(4):964-8. PubMed ID: 403001 [Abstract] [Full Text] [Related]
15. Immunization of DBA/2 mice with a T cell hybridoma-derived TsF increases immune resistance to the syngeneic tumors P815 and L1210. Steele JK, Singhai R, Stammers AT, Levy JG. J Immunol; 1986 Nov 01; 137(9):3025-30. PubMed ID: 3489783 [Abstract] [Full Text] [Related]
16. Improved host defense against L1210 leukemia by deprivation of dietary phenylalanine. Pine MJ. Nutr Cancer; 1981 Nov 01; 3(2):94-102. PubMed ID: 7346795 [Abstract] [Full Text] [Related]
17. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210. Rahman SM, Kawashima K, Nakashima I, Nagase F. Cancer Res; 1988 Nov 15; 48(22):6450-4. PubMed ID: 3263189 [Abstract] [Full Text] [Related]
18. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy. Griswold DP, Trader MW, Frei E, Peters WP, Wolpert MK, Laster WR. Cancer Res; 1987 May 01; 47(9):2323-7. PubMed ID: 3567926 [Abstract] [Full Text] [Related]
19. Hematoporphyrin derivative rescue from toxicity caused by chemotherapy or radiation in a murine leukemia model (L1210). Canti G, Franco P, Marelli O, Ricci L, Nicolin A. Cancer Res; 1984 Apr 01; 44(4):1551-6. PubMed ID: 6231100 [Abstract] [Full Text] [Related]
20. Induction of tumor resistance in mice by L1210 leukemia cells persistently infected with HVJ (Sendai virus). Takeyama H, Kawashima K, Yamada K, Ito Y. Gan; 1979 Aug 01; 70(4):493-501. PubMed ID: 229053 [Abstract] [Full Text] [Related] Page: [Next] [New Search]